Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Staphylococcal protein A - Protalex

Drug Profile

Staphylococcal protein A - Protalex

Alternative Names: PRTX-001; PRTX-100

Latest Information Update: 13 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Protalex
  • Class Antirheumatics; Bacterial proteins; Immunotherapies
  • Mechanism of Action B cell inhibitors; Immunomodulators; Macrophage inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Idiopathic thrombocytopenic purpura
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Idiopathic thrombocytopenic purpura; Rheumatoid arthritis
  • Preclinical Myasthenia gravis
  • No development reported Autoimmune disorders

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 14 Jun 2018 Efficacy and adverse events data in Idiopathic thrombocytopenic pupurea (ITP) presented at 23rd Congress of the European Haematology Association (EHA- 2018)
  • 01 Mar 2018 Protalex plans a phase III trial for Immune thrombocytopenia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top